Non-Clinical Toxicology and Safety Assessment of a Small Molecule

Summary

Helmholtz-Zentrum für Infektionsforschung GmbH is procuring a comprehensive non-clinical toxicology and safety assessment programme for a small-molecule drug candidate. The work includes assessment following intravenous infusion, with particular attention to renal safety, and a dermal toxicology assessment to support potential topical use; the dermal programme is subject to a go/no-go decision. The programme is intended to generate safety data and documentation for regulatory submissions in the EU and the United States, supporting a first-in-human trial and further clinical development.